Company news

Pharvaris N.V. news in 2022

Pharvaris N.V.'s news releases, calls and decks from 2022, newest first.

View company

Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update

December 7, 2022

Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks

December 7, 2022

Pharvaris to Present PHVS416 and PHVS719 Clinical Data for Treatment of HAE at the ACAAI Annual Scientific Meeting 2022

November 9, 2022

Pharvaris Presents Data Supporting HAE Drug Development Strategy at the 2022 HAEi Global Leadership Workshop

October 6, 2022

Pharvaris Announces the Promotion of Annick Deschoolmeester to Chief Human Resources Officer

September 29, 2022

Pharvaris Highlights Data Supporting Clinical Development Program for Hereditary Angioedema at the 2022 Bradykinin Symposium

September 15, 2022

Pharvaris Reports Second Quarter 2022 Financial Results and Provides Business Update

September 11, 2022

Pharvaris Announces FDA Clinical Hold on PHA121 Clinical Trials in the U.S.

August 21, 2022

Pharvaris to Participate in H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) Conference

July 13, 2022

Pharvaris to Host Virtual Expert Perspectives on HAE: Unmet Needs and Therapeutic Options Webinar on July 13

July 5, 2022

Pharvaris Participates in the Kinin 2022 Conference

June 6, 2022

Pharvaris Supports HAE Community by Participating in Company-wide Activities Challenge for May 16th hae day: -)

May 15, 2022

Pharvaris Reports First Quarter 2022 Financial Results and Provides Business Highlights

May 10, 2022

Pharvaris Appoints Joan Schmidt, J.D., as Chief Legal Officer

May 10, 2022

Pharvaris to Participate in BofA Securities 2022 Healthcare Conference

May 4, 2022

Pharvaris to Participate in Upcoming April Investor Conferences

April 5, 2022

Pharvaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

March 28, 2022

Pharvaris Announces Preclinical Pharmacological Data for Small Molecule PHA121 Published in International Immunopharmacology

March 21, 2022

Pharvaris to Participate in Upcoming March Investor Conferences

March 2, 2022

Pharvaris to Participate in 11th Annual SVB Leerink Global Healthcare Conference

February 8, 2022

Decks in 2022